Nuzenio

Spyre

Spyre news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 22 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 20:40:02 GMTSpyre Therapeutics, Inc. SEC Filing (Aug 7, 2026) - Stock Titan
Fri, 07 Aug 2026 20:26:06 GMTSpyre Therapeutics Announces Grants of Inducement Awards - The Manila Times
Fri, 07 Aug 2026 05:38:06 GMTPrice to sales forward of Spyre Therapeutics, Inc – DUS:3920 - TradingView
Fri, 07 Aug 2026 00:17:00 GMTSpyre's CEO Sold Stock, but Kept 567,000 Shares. Here's What Long-Term Investors Should Know - The Motley Fool
Thu, 06 Aug 2026 15:16:29 GMTWe Think Spyre Therapeutics (NASDAQ:SYRE) Can Easily Afford To Drive Business Growth - Moomoo
Thu, 06 Aug 2026 07:14:26 GMTSpyre Therapeutics (SYRE) CEO Cameron Turtle Sells 15,000 Shares - GuruFocus

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Spyre.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.